Which laboratory values typically increase when a patient begins lisinopril (angiotensin‑converting enzyme inhibitor)?

Laboratory Values That Increase with Lisinopril

When starting lisinopril, expect increases in serum potassium, serum creatinine, and blood urea nitrogen (BUN) 1.

Primary Laboratory Changes

Potassium (Most Important)

• Hyperkalemia occurs in 2.2% of hypertensive patients and 4.8% of heart failure patients on lisinopril 1
• Typical increase is modest, around 1 mEq/L 2
• Only 6.4% develop potassium levels ≥5.5 mEq/L in clinical trials 2
• Higher risk in patients with diabetes or chronic kidney disease 2

Clinical Action: Monitor serum potassium early after initiation, reduce dietary potassium, and avoid potassium-sparing diuretics and NSAIDs 2.

Creatinine and BUN

• Minor increases in creatinine and BUN occur in approximately 2% of hypertensive patients treated with lisinopril alone 1
• In heart failure patients on concomitant diuretics, reversible increases occur in 11.6% 1
• The rise is typically 10-20%, occurs promptly, and is not progressive 2
• This reflects hemodynamic changes from ACE inhibition, not true kidney damage 2

Critical Distinction: An acute creatinine rise up to 30% that stabilizes within the first 2 months is actually associated with long-term renal protection and should NOT prompt drug discontinuation 3. Only withdraw lisinopril if creatinine rises >30% above baseline within 2 months, or if severe hyperkalemia develops (≥5.6 mmol/L) 3.

Laboratory Values That May Decrease

Hemoglobin and Hematocrit

• Small decreases occur frequently (mean decrease ~0.4 g% hemoglobin, 1.3 vol% hematocrit) 1
• Rarely clinically significant unless other causes of anemia present
• Less than 0.1% discontinue therapy due to anemia 1

Monitoring Strategy

At initiation:

1. Check baseline potassium, creatinine, and BUN
2. Recheck within 1-2 weeks after starting
3. Monitor again at 2 months to assess stability

Common pitfall: Discontinuing lisinopril for a modest creatinine rise of 10-30% is inappropriate and deprives patients of long-term renal protection 3. The inverse relationship between early creatinine rise and subsequent renal decline is well-established—patients with baseline creatinine ≥1.4 mg/dL who experience this early rise show 55-75% risk reduction in renal disease progression 3.

Red flags requiring discontinuation:

• Creatinine increase >30% within 2 months 3
• Potassium ≥5.6 mmol/L 3
• Signs of bilateral renal artery stenosis (acute renal failure with oliguria/anuria) 2
• Volume depletion or hypotension (MAP <65 mmHg) 2